polycyclic compounds

Preferred Label : polycyclic compounds;

MeSH definition : Compounds consisting of two or more fused ring structures.; Compounds which contain two or more rings in their structure.;

MeSH synonym : compounds, polycyclic;

CISMeF synonym : hydrocarbons, polycyclic;

MeSH hyponym : polycyclic hydrocarbons;

Wikipedia link : https://en.wikipedia.org/wiki/Polycyclic compounds;

Is substance : O;

Details

Origin ID

D011083;

UMLS CUI

C0032456;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Polycyclic compound (substance) [SNOMED CT concept]
Indexing information
- allocyathin B2 [MeSH Supplementary Concept]
- scabronine E [MeSH Supplementary Concept]
Metaterm(s)
- chemistry [CISMeF Metaterm]
Record concept(s)
- polycyclic compounds [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2.2)paracyclophane [MeSH Supplementary Concept]
- (2.2)paracyclophaneacetic acid [MeSH Supplementary Concept]
- (7.7)paracyclophane [MeSH Supplementary Concept]
- 1,2,3,10,11,12-hexamethoxy-6,7-dihydroxy-6,7-dimethyldibenzocyclooctadiene [MeSH Supplementary Concept]
- 1,2,4a,5,6,7,8,9,10,10a,11,11a-dodecahydro-11-hydroxy-11-methyl-7-phenylthiomethyl-5aH-5a,8-methanocyclohepta(b)naphthalen-10-one [MeSH Supplementary Concept]
- 1,2-benzocyclodecen-3-ol [MeSH Supplementary Concept]
- 1,2-benzocyclononen-3-ol [MeSH Supplementary Concept]
- 1,2-diketopyracene [MeSH Supplementary Concept]
- 1-((7-oxo-7H-benzo(de)anthracen-3-ylcarbamoyl)methyl)triethylammonium [MeSH Supplementary Concept]
- 1-aminobenz(f)indan-2-ol [MeSH Supplementary Concept]
- 1-nitrocoronene [MeSH Supplementary Concept]
- 14-O-((4-aminobenzamide-2-methylpropane-2-yl)thioacetate)mutilin [MeSH Supplementary Concept]
- 16-isopropyl-5, 9-dimethyltetracyclo(10.2.2.0(1,10).0(4,9))hexadec-15-ene-5,14-dicarboxylic acid [MeSH Supplementary Concept]
- 2,3,9,10-tetrakis(trimethylsilyl)pentacene [MeSH Supplementary Concept]
- 2,7,12-trihexyloxytruexene [MeSH Supplementary Concept]
- 2-formyl-7,8-dipropyltetrathia(7)helicene [MeSH Supplementary Concept]
- 2S-hydroxymutilin [MeSH Supplementary Concept]
- 3,4-seco-entkaurene [MeSH Supplementary Concept]
- 3,6-dibromophencyclone [MeSH Supplementary Concept]
- 3-(((2,2-dimethyl-1-(((2-methoxy-1-phenylethyl)amino)carbonyl)propyl)amino)carbonyl)-6-(3-methyl-4-phenylphenyl)hexanoic acid [MeSH Supplementary Concept]
- 3beta-stearyloxy-urs-12-ene [MeSH Supplementary Concept]
- 4,12-bis(diphenylphosphino)-(2.2)paracyclophane [MeSH Supplementary Concept]
- 4,21-deacetyl-deoxyyuzurimine [MeSH Supplementary Concept]
- 4,4a,6-trihydroxy-5-methoxyfluoren-2,9-dione [MeSH Supplementary Concept]
- 4,6-O-benzylidene-erythro-2-3-dideoxyhex-2-enopyranoside [MeSH Supplementary Concept]
- 4-((10-allyl-9,10-diazatricyclo(4.2.1.12,5)dec-9-yl)-(3-methoxyphenyl)methyl)-N,N-diethylbenzamide [MeSH Supplementary Concept]
- 4-(1a,6-dihydro-1H-cyclopropa(a)inden-6a-yl)-1H-imidazole [MeSH Supplementary Concept]
- 4-nitro-13-amino-(2,2)paracyclophane [MeSH Supplementary Concept]
- 4-sulfo-benzocyclobutene [MeSH Supplementary Concept]
- 7,8-diropyltetrathia(7)helicene [MeSH Supplementary Concept]
- A-317491 [MeSH Supplementary Concept]
- A-74528 [MeSH Supplementary Concept]
- AQX MN100 [MeSH Supplementary Concept]
- AT-11 compound [MeSH Supplementary Concept]
- FR 182877 [MeSH Supplementary Concept]
- FluoZin-3 [MeSH Supplementary Concept]
- GR135402 [MeSH Supplementary Concept]
- GSQ1530 [MeSH Supplementary Concept]
- MPT0B292 [MeSH Supplementary Concept]
- NOTA-PRGD2 [MeSH Supplementary Concept]
- NSC 644221 [MeSH Supplementary Concept]
- Org 306039 [MeSH Supplementary Concept]
- S 50131 [MeSH Supplementary Concept]
- S 51434 [MeSH Supplementary Concept]
- STA-21 [MeSH Supplementary Concept]
- TAN-1085 [MeSH Supplementary Concept]
- WMJ-8-B [MeSH Supplementary Concept]
- acepentalene [MeSH Supplementary Concept]
- adenocaulone [MeSH Supplementary Concept]
- alkaloid GB22 [MeSH Supplementary Concept]
- amethystin [MeSH Supplementary Concept]
- aoibaclyin [MeSH Supplementary Concept]
- artochamin H [MeSH Supplementary Concept]
- artochamin I [MeSH Supplementary Concept]
- asterosaponin 1 [MeSH Supplementary Concept]
- azonia(6)helicene [MeSH Supplementary Concept]
- benzo (7)annulen-7-amine [MeSH Supplementary Concept]
- benzocyclobutene [MeSH Supplementary Concept]
- benzotricyclo(3.2.1.0(2,7))octane [MeSH Supplementary Concept]
- betamethylepoxide [MeSH Supplementary Concept]
- bicalicene [MeSH Supplementary Concept]
- brevisin [MeSH Supplementary Concept]
- butapren [MeSH Supplementary Concept]
- butyl 2-cyano-3, 11-dioxours-1,12-dien-24-oate [MeSH Supplementary Concept]
- calyciphylline A [MeSH Supplementary Concept]
- calyciphylline B [MeSH Supplementary Concept]
- calyciphylline N [MeSH Supplementary Concept]
- calyciphylline O [MeSH Supplementary Concept]
- calyciphylline P [MeSH Supplementary Concept]
- carbaplatensimycin [MeSH Supplementary Concept]
- carboxyethylester-polyrotaxane [MeSH Supplementary Concept]
- ceratopicanol [MeSH Supplementary Concept]
- clarified slurry oil [MeSH Supplementary Concept]
- coronene [MeSH Supplementary Concept]
- cortistatin A [MeSH Supplementary Concept]
- cryptophane [MeSH Supplementary Concept]
- cryptophane A [MeSH Supplementary Concept]
- cryptophane E [MeSH Supplementary Concept]
- cryptophane-111 [MeSH Supplementary Concept]
- cryptophane-D [MeSH Supplementary Concept]
- cyclofen [MeSH Supplementary Concept]
- cyclotriveratrylene [MeSH Supplementary Concept]
- daphniglaucin C [MeSH Supplementary Concept]
- dechlorane 602 [MeSH Supplementary Concept]
- dechlorane 603 [MeSH Supplementary Concept]
- dechlorane plus [MeSH Supplementary Concept]
- dehydrobenzo(12)annulene [MeSH Supplementary Concept]
- dehydrohomoplatencin [MeSH Supplementary Concept]
- dibenzo(a,e)cyclooctadiyne [MeSH Supplementary Concept]
- dibenzobicyclo(2.2.2)octane [MeSH Supplementary Concept]
- dideoxy lomaiviticinone [MeSH Supplementary Concept]
- dihydro-dicyclohepta(ed,gh)pentalene [MeSH Supplementary Concept]
- dihydrodicyclopenta(ef,kl)heptalene [MeSH Supplementary Concept]
- distachyasin [MeSH Supplementary Concept]
- distillate aromatic extract [MeSH Supplementary Concept]
- dodecahedrane [MeSH Supplementary Concept]
- dodecahydro-7-(2-hydroxyethyl)-3a-methyl-1H-benz(e)indene-3-carbonitrile [MeSH Supplementary Concept]
- endo-5-methoxy-3-patchoulene [MeSH Supplementary Concept]
- erdacin [MeSH Supplementary Concept]
- ethynylhelicene [MeSH Supplementary Concept]
- euphorbia factor L2 [MeSH Supplementary Concept]
- funalenone [MeSH Supplementary Concept]
- garcibracteatone [MeSH Supplementary Concept]
- gomisin D [MeSH Supplementary Concept]
- gomisin J [MeSH Supplementary Concept]
- helicenediamine [MeSH Supplementary Concept]
- helicenes [MeSH Supplementary Concept]
- heliomycin [MeSH Supplementary Concept]
- heptacene [MeSH Supplementary Concept]
- hexa-peri-hexabenzocoronene [MeSH Supplementary Concept]
- hexacyclinol [MeSH Supplementary Concept]
- hyrtiosal [MeSH Supplementary Concept]
- isokobusone [MeSH Supplementary Concept]
- isoschizandrin [MeSH Supplementary Concept]
- lefamulin [MeSH Supplementary Concept]
- lepistine [MeSH Supplementary Concept]
- leucothol A [MeSH Supplementary Concept]
- lundurine A [MeSH Supplementary Concept]
- lundurine B [MeSH Supplementary Concept]
- lusianthrin [MeSH Supplementary Concept]
- lyconadin A [MeSH Supplementary Concept]
- lyconadin B [MeSH Supplementary Concept]
- lyconadin C [MeSH Supplementary Concept]
- macropodumine A [MeSH Supplementary Concept]
- macropodumine B [MeSH Supplementary Concept]
- macropodumine C [MeSH Supplementary Concept]
- macropodumine D [MeSH Supplementary Concept]
- macropodumine E [MeSH Supplementary Concept]
- macropodumine L [MeSH Supplementary Concept]
- maristentorin [MeSH Supplementary Concept]
- meloscine [MeSH Supplementary Concept]
- meso-dibenzoporphycene [MeSH Supplementary Concept]
- methyl 4,6-O-benzylidene-2-C-methoxycarbonylmethyl-ribo-hexopyranosid-3-ulose [MeSH Supplementary Concept]
- mutilin [MeSH Supplementary Concept]
- mutilin 14-O-(1-(1-methyl-4-nitro-3-propyl-1H-pyrazolecarboxamide)-2-methylpropane-2-yl)thioacetate [MeSH Supplementary Concept]
- neopetrocyclamine A [MeSH Supplementary Concept]
- neopetrocyclamine B [MeSH Supplementary Concept]
- nivetetracyclate A [MeSH Supplementary Concept]
- nivetetracyclate B [MeSH Supplementary Concept]
- nona-octanoyloxy tribenzocyclononatriene [MeSH Supplementary Concept]
- octahydro-7,7,8,8-tetramethyl-2,3b-methano-3bH-cyclopenta(1,3)cyclopropa(1,2)benzene-4-methanol [MeSH Supplementary Concept]
- pallidol [MeSH Supplementary Concept]
- pentacycloanammoxic acid methyl ester [MeSH Supplementary Concept]
- perfluorododecahedrane [MeSH Supplementary Concept]
- perinadine A [MeSH Supplementary Concept]
- phencyclone [MeSH Supplementary Concept]
- pieristoxin F [MeSH Supplementary Concept]
- pieristoxin G [MeSH Supplementary Concept]
- platencin [MeSH Supplementary Concept]
- pleuromutilin [MeSH Supplementary Concept]
- plukenetione A [MeSH Supplementary Concept]
- poly(pentaphenylene) [MeSH Supplementary Concept]
- popolohuanone E [MeSH Supplementary Concept]
- pradimicin M [MeSH Supplementary Concept]
- pradimicin O [MeSH Supplementary Concept]
- pradimicin P [MeSH Supplementary Concept]
- pseudo-para-divinyl(2.2)paracyclophane [MeSH Supplementary Concept]
- pyrenophane [MeSH Supplementary Concept]
- racemosolone [MeSH Supplementary Concept]
- retigeranic acid A [MeSH Supplementary Concept]
- ripromycin [MeSH Supplementary Concept]
- rubschisandrin [MeSH Supplementary Concept]
- salvadione-A [MeSH Supplementary Concept]
- schisanhenol [MeSH Supplementary Concept]
- schisanhenol B [MeSH Supplementary Concept]
- schisantherin B [MeSH Supplementary Concept]
- schisantherin C [MeSH Supplementary Concept]
- schizandrin [MeSH Supplementary Concept]
- schizandrin A [MeSH Supplementary Concept]
- schizandrin B [MeSH Supplementary Concept]
- schizandrin C [MeSH Supplementary Concept]
- selaginpulvilin D [MeSH Supplementary Concept]
- stentorin I [MeSH Supplementary Concept]
- stentorin II [MeSH Supplementary Concept]
- suaveolol [MeSH Supplementary Concept]
- syntower bottoms [MeSH Supplementary Concept]
- tercyclopropanedimethanol [MeSH Supplementary Concept]
- tetarimycin A [MeSH Supplementary Concept]
- tetracyclo(4.2.1.1(3,6).0(2,7))dodeca-4,9-diene [MeSH Supplementary Concept]
- tetrathia(7)-helicene [MeSH Supplementary Concept]
- tricyclo(2.1.0.0 1,3)pentasilane [MeSH Supplementary Concept]
- tricyclo(2.1.0.0(1,3))pentagermane [MeSH Supplementary Concept]
- tricyclo(3.2.1.0(2,4))oct-6-ene [MeSH Supplementary Concept]
- tricyclo(4.1.0.0(2,7))heptene [MeSH Supplementary Concept]
- triethyl-2,5,8- tribenzyltrindane-2,5,8-tricarboxylate [MeSH Supplementary Concept]
- triptycyl(4)helicene [MeSH Supplementary Concept]
- tris(2-(4-phenyldiazenyl)phenylaminoethoxy)cyclotriveratrylene [MeSH Supplementary Concept]
- xylindein [MeSH Supplementary Concept]
See also
- heterocyclic compounds [MeSH Descriptor]
- hydrocarbons, cyclic [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Polycyclic compound (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients